Article Text

Download PDFPDF
The authors’ reply
  1. Shane George,
  2. Kay Dhadwal,
  3. Sharif Al-Ruzzeh,
  4. Thanos Athanasiou,
  5. Marina Choudhury,
  6. Paris Tekkis,
  7. Pynee Vuddamalay,
  8. Haifa Lyster,
  9. Mohamed Amrani
  1. Harefield Hospital, Harefield, UK
  1. Shane George, Harefield Hospital, UB9 6JH, UK; shanegeorge{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We thank Drs Mclaren et al for their interest in our study.

First, we chose vancomycin as we wished to use an antistaphylococcal drug that had been studied in cardiac surgical patients. Additional rifampicin was used in an attempt to prevent resistance developing. Clearly the strategy was successful as we did not see any increase in resistant organisms during, or for the 2 years after, the study. We are interested in their statement that no difference resulted from a change in their antibiotic prophylaxis. This statement was unpublished and is not publicly available. They have chosen to …

View Full Text


  • Competing interests: None declared.